HF
MRSN

HRT Financial’s Mersana Therapeutics MRSN Stock Holding History

HRT Financial’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,735
Closed -$27K – 3434
2025
Q2 		$27K Buy
3,735
+1,875
+101% +$16.5K ﹤0.01% 2367
2025
Q1 		$16K Buy
+1,860
New +$28.7K ﹤0.01% 2321
2024
Q3 		– Sell
-10,388
Closed -$521K – 2910
2024
Q2 		$521K Buy
+10,388
New +$751K ﹤0.01% 1286
2024
Q1 		– Sell
-4,233
Closed -$245K – 2819
2023
Q4 		$245K Buy
4,233
+1,666
+65% +$67K ﹤0.01% 1706
2023
Q3 		$81K Buy
+2,567
New +$122K ﹤0.01% 1967
2023
Q1 		– Sell
-448
Closed -$65K – 2953
2022
Q4 		$65K Sell
448
-4,065
-90% -$687K ﹤0.01% 2101
2022
Q3 		$762K Buy
+4,513
New +$733K 0.01% 1104
2022
Q2 		– Sell
-7,043
Closed -$702K – 3449
2022
Q1 		$702K Buy
7,043
+2,366
+51% +$276K 0.01% 1381
2021
Q4 		$727K Buy
+4,677
New +$910K ﹤0.01% 1474
2021
Q2 		– Sell
-1,276
Closed -$516K – 3293
2021
Q1 		$516K Buy
+1,276
New +$619K 0.01% 1752

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return